Samsung Group in talks to buy Biogen (BIIB) - Korean Economic Daily
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/6/2026
- S&P 500, Nasdaq reach record closing highs as focus pivots to earnings
- Oil prices fall nearly 2% as Middle East supply concerns ease
- U.S. 10-year yield climb revives dotcom-era parallels: UBS weighs in
- Goldman flags 2 key market risks if a climb in yields persists
- Shell CEO says Middle East oil flows reach 80% of prewar levels
- HubSpot to cut 7% of workforce in restructuring plan
- Paramount Skydance to close WBD deal, change ticker to SKYD
- Citi cuts investment banking analyst program to two years - Bloomberg
- Emera and Canadian Utilities agree to merge in $72B all-share deal
- Nasdaq notches record high close as investors focus on earnings
Samsung BioLogics Said Biogen (BIIB) Buyout Rumor 'Untrue'
December 29, 2021 11:59 PM ESTSamsung BioLogics said a report that Samsung Group was in talks to acquire Biogen Inc. (NASDAQ: BIIB) is not true.
... MoreBiogen (BIIB) Could be Valued at $42B Cash in Samsung Deal, Here Are Key Questions According to Truist Securities
December 29, 2021 5:01 PM ESTTruist analyst Robyn Karnauskas reiterates a "Buy" rating and $502 price target on shares of Biogen (NASDAQ: BIIB), following rumors of potential takeover of the company by Samsung Group.
The analyst quotes:
"While there is no price set yet, Biogen approached Samsung to... More


